Anti-Inflammatories
Cutting back on steroid drops after cataract surgery: What are the alternatives?
Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a society of cornea, cataract and refractive surgery specialists, here to discuss some of the latest hot topics in ophthalmology.
Current Approved Pharmacological Therapies
Annual anti-inflammatory review
It is September once again, time for us to review the state of the anti-inflammatory landscape in the world of dry eye disease.
Eicosapentaenoic acid appears to counteract harmful CV effects from air pollution
Eicosapentaenoic acid, the active ingredient in certain omega-3 fatty acids, promoted anti-inflammatory, cytoprotective and lipid changes in endothelial cells exposed to air pollution, researchers reported.
ALL-HEART
Allopurinol compared with usual care in patients with ischemic heart disease.
Allopurinol fails to improve outcomes in ischemic heart disease
In patients with ischemic heart disease older than 60 years, the uric acid-lowering drug allopurinol did not improve CV outcomes, according to results of the ALL-HEART trial presented at the European Society of Cardiology Congress.
Colchicine as COVID-19 treatment suffers difficult year, but some hope remains
If colchicine and its prospects as a COVID-19 treatment entered 2021 with a bang, then it decidedly exited the year with a whimper.
Beta-blockers, anti-inflammatory therapies improved pericarditis symptom control
The use of beta-blockers in addition to standard anti-inflammatory therapies may improve symptom control in patients with pericarditis, according to results published in The American Journal of Cardiology.